Cargando…

The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575757/
https://www.ncbi.nlm.nih.gov/pubmed/36254094
http://dx.doi.org/10.1097/MD.0000000000031359
_version_ 1784811380923170816
collection PubMed
description
format Online
Article
Text
id pubmed-9575757
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95757572022-10-17 The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum Medicine (Baltimore) Erratum Lippincott Williams & Wilkins 2022-10-14 /pmc/articles/PMC9575757/ /pubmed/36254094 http://dx.doi.org/10.1097/MD.0000000000031359 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Erratum
The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
title The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
title_full The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
title_fullStr The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
title_full_unstemmed The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
title_short The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
title_sort relationship between nlr/plr/lmr levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575757/
https://www.ncbi.nlm.nih.gov/pubmed/36254094
http://dx.doi.org/10.1097/MD.0000000000031359